SCHEMBL14965757

SCHEMBL14965757

Nc1ccc2cnn(C3CCC3)c(=O)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 1/20 0.40
RGS12 O14924 1/20 0.40
NPC1 O15118 1/20 0.40
USP2 O75604 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE9A O76083 6/20 0.38
PDE1C Q14123 2/20 0.38
GRM1 Q13255 1/20 0.38
PDE7A Q13946 3/20 0.36
PDE7B Q9NP56 2/20 0.36
PDE4D Q08499 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14966264 0.96 KDM4E (0.44) KDM4EMEN1RGS12NPC1USP2
SCHEMBL14965908 0.85 AURKA (0.39) KDM4EMEN1RGS12NPC1USP2
SCHEMBL14965951 0.84 PI4KB (0.32) KDM4EMEN1RGS12NPC1USP2
SCHEMBL14965954 0.84 PI4KB (0.32) KDM4EMEN1RGS12NPC1USP2
SCHEMBL14966310 0.80 SIRT2 (0.40) MEN1NPC1RAB9AKMT2AALDH1A1
SCHEMBL30778591 0.77 KDM4E (0.43) KDM4EMEN1RGS12NPC1USP2
SCHEMBL14966507 0.76 SIRT2 (0.44) MEN1NPC1HTTRAB9AKMT2A
SCHEMBL29703260 0.76 GAA (0.47) MEN1NPC1RAB9AKMT2AALDH1A1
SCHEMBL24861043 0.75 CRBN (0.57)
SCHEMBL5195277 0.74 PDE1B (0.50) PDE9APDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072825-A1 PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-05-23 WO disclosed
WO-2013072825-A1 PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-05-23 WO disclosed